The BET-bromodomain inhibitor OTX015 (MK-8628) exerts in vitro and in vivo anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

NIAID Data Ecosystem2026-03-10 收录

三阴性乳腺癌治疗

BET抑制剂

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE79721 数据链接链接失效反馈

官方服务：

资源简介：

assess the efficacy of OTX015 (MK-8628) BET inhibitor in vitro and in vivo triple negative breast cancer models GEP analysis of 2 breast cancer cell lines with and without treatment at different timepoints

创建时间：

2018-08-13

The BET-bromodomain inhibitor OTX015 (MK-8628) exerts in vitro and in vivo anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus

资源简介：

相关数据集